Breast cancer is the most common cancer among women and is typically managed through
surgery, radiation therapy, and chemotherapy. However, chemotherapy drugs often lack …

Lipid-based polymeric nanoparticles are the highly popular carrier systems for cancer drug
therapy. But presently, detailed investigations have revealed their flaws as drug delivery …

Despite significant treatment advances, breast cancer remains the leading cause of cancer
death in women. From the current treatment situation, in addition to developing …

The non-specificity of standard anticancer therapies has profound detrimental
consequences in clinical treatment. Therapeutic specificity can be precisely achieved using …

Discovering novel cancer therapies has attracted extreme interest in the last decade. In this
regard, multidrug resistance (MDR) to chemotherapies is a key challenge in cancer …

Small interfering RNA (siRNA) delivery by nanocarriers has been identified as a promising
strategy in the study and treatment of cancer. Short nucleotide sequences are synthesized …

Silencing genes using small interfering (si) RNA is a promising strategy for treating cancer.
However, the curative effect of siRNA is severely constrained by low serum stability and cell …

Cancer is the second leading cause of death after heart disease. It forms clusters of
immature cells, spreads through metastasis, and invades normal tissue. Chemotherapeutic …

Mesoporous silica nanoparticles (MSNs), as novel nanocarriers for drug delivery in cancer
treatment, have attracted widespread concern because of their rich pore structure, large …

Chemotherapy has been widely used for cancer therapy but with unsatisfied efficacy, mainly
due to the inefficient delivery of anticancer agents. Among the critical “five steps” drug …